$IZEA

IZEA Announces Q3 2025 Earnings Results Conference Call

ORLANDO, Fla., Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- IZEA Worldwide, Inc. ( NASDAQ: IZEA ) , a leading influencer marketing company that makes Creator Economy solutions for marketers, announced today that its conference call to review and discuss its third quarter 2025 financial results will begin ...

Original reporting
GlobeNewswire · IZEA Worldwide, Inc.
Published Nov 3, 2025, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 3, 2025, 8:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IZEA Announces Q3 2025 Earnings Results Conference Call — source image
Decision brief

The 30-second read

$IZEANeutralMed
01

Why it matters

Earnings results could influence short-term stock price movements, especially if they deviate from analyst expectations.

02

Market read

The news is highly relevant for traders interested in the influencer marketing sector and IZEA's stock performance around earnings releases.

03

What to watch

Potential macroeconomic headwinds or sector-specific issues not reflected in current sentiment.

Timing: High, as the earnings call is scheduled shortly after publication.

Background

IZEA Worldwide is a leading influencer marketing company scheduled to report Q3 2025 financial results.

Company-level read

Ticker impact

$IZEANeutralMedium confidence
Context

The news pertains directly to IZEA Worldwide's upcoming earnings call, indicating potential short-term trading opportunities.

Expected impact

Moderate increase expected post-earnings, with potential short-term volatility.

Evidence & confidence

Earnings announcements typically influence stock prices; however, the neutral sentiment score suggests no immediate strong positive or negative bias.

Market effects

Potential positive impact on the influencer marketing sector if earnings beat expectations.

Limited regional impact, primarily affecting US-based investors.

Minimal global relevance beyond sector influence.

Counterpoint

Earnings may underperform due to sector challenges, leading to a decline in stock price.

Key entities

  • IZEA Worldwide

    A leading influencer marketing company providing Creator Economy solutions.

Related articles

$IZEAMedAI 8/10

IZEA (IZEA) Q2 2026 Earnings Call Transcript

IZEA reported Q2 2026 revenue of $5.8M, down 36% YoY, and a net loss of $0.7M, as it shifts to larger enterprise accounts. Managed services bookings fell 19% YoY, while SaaS revenue declined 32%. The company has $46.6M in cash and no long-term debt. Management highlighted new enterprise wins and an active M&A pipeline, but noted macroeconomic uncertainty.

$IZEAMed

IZEA Worldwide, Inc. (IZEA): Results of Operations and Financial Condition

IZEA Worldwide, Inc. (IZEA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991pressreleaseq220.htm EX-99.1 Document IZEA Reports Q2 2026 Revenue of $5.8 million, Advances Enterprise-Focused Growth Strategy Enterprise Relationships Remain Strong Amid Market Uncertainties ORLANDO, Fla. ( August 11, 2026 ) - IZEA Worldwide, Inc. (NASDAQ: I

$RBAHigh

Why This U.S. Auto Retail Stock is Barclays’ Top Pick Right Now

Barclays named RB Global Inc (RBA) its top U.S. auto retail pick, citing an attractive valuation at 12.7x EV/EBITDA, market share gains, and cyclical improvements in its Heavy Equipment & Transportation segment. RBA reported Q2 2026 revenue of $1.32B, beating estimates, with 11% gross transaction value growth. Barclays expects RBA to gain market share from Copart Inc (CPRT) in the salvage vehicle auction market.

$GHHighAI 8/10

Guardant ordered to pay $245m in DNA sequencing patent dispute

Guardant Health was ordered to pay $245.2m to TwinStrand Biosciences and the University of Washington for patent infringement. The ruling covers 11 products, including Guardant360 CDx, and includes damages, royalties, and interest. Guardant plans to appeal, while TwinStrand affirms its commitment to its intellectual property.

$KURAMed

Why is Kura Oncology stock surging today?

Kura Oncology's stock rose 11.6% in pre-market trading after CEO Troy Wilson bought 100,000 shares for $1.24 million, his second large purchase in a week. Analysts Citigroup and Jefferies reaffirmed positive ratings, citing strong commercial momentum for KOMZIFTI and Q2 earnings beat. The stock surpassed its 52-week high of $12.90.

$BEMed

Nancy Pelosi Made Millions On Nvidia Options. Now She’s Betting $3 Million On 1 AI Energy Stock

Paul Pelosi, spouse of House Speaker Nancy Pelosi, acquired 15,000 shares and 200 call options of Bloom Energy (BE) in July 2026, with a potential investment ranging from $3 million to $12 million. Bloom Energy reported Q2 2026 revenue of $1.065 billion, up 165.5% year-over-year, and raised full-year guidance to $3.9 billion to $4.2 billion. The stock closed at $204.02 on August 24, 2026, up 134.8% year-to-date. The Pelosi household also added to an existing Intel (INTC) position.